Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

Global pharma major Lupin Limited (Lupin) will present data from its phase 1a clinical trial evaluating LNP3693, a STING agonist, at the ESMO Congress in Berlin, Germany, from October 17 to October 21 ...

Visual content depicting climate activists emphasizes emotion and disruption, contrasting with the rational, data-driven ...

The randomized, double-blind, placebo-controlled, parallel-group Phase 2a M-ACCEL trial (ClinicalTrials.gov: (NCT05979779) evaluated HU6 at 150 mg, 300 mg, and 450 mg once daily for 26 weeks in adults ...

-- 11 new abstracts including MASH data to be presented at the 76th Annual AASLD The Liver Meeting (R), 7-11 November -- Highlights include data from post-hoc analyses of the ESSENCE trial ...

In other words, we can use AI as a simulated audience: a stand-in that reacts to a data story as if it were a specific type ...

The right preparation ensures you make the most out of an opportunity to share your story through a fireside chat.

Six honors students and 130 undergraduates will conduct a student-designed exit poll in Charlottesville precincts.

New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie (ABBV)'s growing ADC portfolio designed to target ...

DUBLIN and CHICAGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections ...

Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- ...